R&G PharmaStudies (301333) Stock Overview

R&G PharmaStudies Co., Ltd. provides clinical research outsourcing services for pharmaceutical and medical device companies, and scientific research institutions in China. It offers clinical trial consulting, clinical trial operation, data management and statistical analysis, technical services and solutions, biostatistical quantitative scientific support, and various services related to the clinical trial data monitoring committee, including participating in the committee or relevant statistical analysis for the committee. The company also provides clinical pharmacology services; biological sample testing services to analyze and detect the biological samples collected during the clinical trial, and to determine the concentration of the original drug and/or metabolites; and clinical trial site management services. The company was founded in 2008 and is based in Beijing, China.